Published in
Taylor and Francis Group, Biomarkers, 5(26), p. 417-424, 2021
DOI: 10.1080/1354750x.2021.1905067
Links
Tools
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19
Journal article published in 2021 by
Kevin Roedl,
Dominik Jarczak 
,
Marlene Fischer,
Munif Haddad,
Olaf Boenisch,
Geraldine de Heer,
Christoph Burdelski,
Daniel Frings,
Barbara Sensen,
Mahir Karakas,
Stefan Kluge,
Axel Nierhaus
,
Marlene Fischer,
Munif Haddad,
Olaf Boenisch,
Geraldine de Heer,
Christoph Burdelski,
Daniel Frings,
Barbara Sensen,
Mahir Karakas,
Stefan Kluge,
Axel Nierhaus
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 